Navigation Links
Big Pharma and Universities Increasingly Work to Advance Life Science Knowledge by Forming Strategic Partnerships, Public-Private Partnerships, and Open Innovation Programs: Pharmaceutical Research Collaborations Summit
Date:6/15/2012

NEW YORK, June 15, 2012 /PRNewswire/ -- ExL Pharma will host the 2nd Pharmaceutical Research Collaborations Summit August 14-15 at the Hyatt Harborside in Boston.

One of the critical questions facing the pharmaceutical industry today is where will future R&D dollars come from. The patent cliff and other forces are making it difficult for large pharmaceutical companies to maintain large-scale internal research departments.  As a result, pharmaceutical companies frequently look outside of their company to benefit from discoveries that may be further along the development pipeline, reducing the financial risk of bringing them further.

The two-day program focuses on various strategies pharmaceutical companies take to benefit from outside research. Sessions will highlight case studies on partnerships between large pharmaceutical and biotech companies, universities, small biotechs, and virtual pharma companies.  Panelists will discuss the different goals of the different institutions, venture capital opportunities, and intellectual property considerations.  Attendees will hear presentations on open innovation case studies, regulatory issues, and the finer points of alliance management.

The diverse speaker staff draws from some of the leading life science research institutions and companies, including MIT, Abbott Ventures, Boston University, Biogen Idec, Tufts, Merck, Millennium, Novartis, Yale, Pfizer, Sanofi, and more. These different points of view will shed light on the dynamics that promise to drive scientific research in coming years.

To find out more information regarding attending the 2nd Pharmaceutical Research Collaborations Summit, please contact Shari Gelfand on sgelfand@exlpharma.com or visit

SOURCE ExL Pharma
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Auxilium Pharmaceuticals, Inc. to Present at the Jefferies 2012 Global Healthcare Conference
2. Rising Interest of Big Pharma Creates Immense Growth Potential for Contract Manufacturing Organisations, Says Frost & Sullivan
3. Questcor Pharmaceuticals to Present at Jefferies 2012 Global Healthcare Conference
4. Genesis Biopharma Mentioned Favorably in BioMedReports Article
5. Genesis Biopharma Issues Letter To Shareholders
6. New Competitive Arena Emerges for Pharmaceutical Companies in Healthcares Changing Payment Landscape, Finds PwC Health Research Institute Study
7. Questcor Pharmaceuticals Expands Repurchase Program
8. PharmAthene Reports First Quarter 2012 Financial Results
9. Eutropics Pharmaceuticals Receives U.S. Patent for Novel Diagnostic Method
10. PDL BioPharma to Present at Upcoming Conferences
11. China Pharma Holdings, Inc. to Report First Quarter of Fiscal Year 2012 Financial Results on May 15, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... June 18, 2013 ... ) has announced the addition of ... & Stable Isotopes Market [SPECT/PET Radioisotopes ... Y-90)], [Applications (Cancer/Oncology, Cardiac)] & (Deuterium, ... report to their offering. ...
(Date:6/18/2013)... 18, 2013 PathoGenetix, Inc. ... for rapid bacterial strain typing, announced today that ... company as Vice President of Engineering. Dr. Luckey ... company’s RESOLUTION™ Microbial Genotyping System . The ... instrument, pathogen-specific assay kits, database and software, will ...
(Date:6/18/2013)... UT (PRWEB) June 18, 2013 NuView ... generation imaging and in vitro diagnostic (IVD) biomarkers, today ... NuView’s novel urine screen in development for the early ... was presented in an oral presentation at the 2013 ... Molecular Imaging (SNMMI) in Vancouver, Canada on Sunday, June ...
(Date:6/17/2013)... Miami, FL (PRWEB) June 17, 2013 As ... Action are committed to finding a cure all for acne, ... Month, the AARS (Acne and Rosacea Society) ... skin conditions, and helping to educate the public on treatment ... leading society by announcing their daily news updates via social ...
Breaking Biology Technology:North American Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market - Forecast to 2017 2North American Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market - Forecast to 2017 3PathoGenetix Hires Technology Development VP for Resolution Microbial Genotyping System 2PathoGenetix Hires Technology Development VP for Resolution Microbial Genotyping System 3NuView Life Sciences Announces Presentation of Data for Novel Prostate and Bladder Cancer Molecular Diagnostic at SNMMI 2NuView Life Sciences Announces Presentation of Data for Novel Prostate and Bladder Cancer Molecular Diagnostic at SNMMI 3Acne and Rosacea Awareness Month: Probiotic Action Announces their Daily News Updates with Insight on the Most Common Skin Conditions 2
... more tech companies by offering tax credits, bringing the ... , ,Governor Jim Doyle on Monday added three biotechs, one ... state's Act 255 was passed last year to ... tax credits for investors. , ,This week's five companies were: ...
... Health and Human Services secretary and longtime Wisconsin governor, ... leaving his Cabinet post in January. , ,Thompson accepted ... Deloitte & Touche USA; law partner at Washington power ... of La Crosse-based Logistics Health Inc., a privately held ...
... Researchers led by James Dahlberg, a founder of Madison-based ... a super-small genetic element may play a critical role in ... by Dahlberg and collaborator Wayne Tam at the Joan and ... week in the Proceedings of the National Academy of Sciences ...
Cached Biology Technology:Tommy Thompson tackles the private sector in spades 2Third Wave co-founder shoots for small target in latest project 2
(Date:6/18/2013)... shows that weight gain and increased head size in the first ... at early school age. , The study was led by University ... 13,800 children who were born full-term. , The results, published in ... put on 40% of their birthweight in the first four weeks ... six years of age, compared with babies who only put on ...
(Date:6/17/2013)... eat their food may turn out to be just as ... out of St. Michael,s Hospital. , The study, led ... association between poor eating habits in kids ages three ... cholesterol, putting them at risk for cardiovascular disease later ... Canadian Medical Association Journal today. , "We know ...
(Date:6/17/2013)... help delay early onset of puberty in girls, a ... at The Endocrine Society,s 95th Annual Meeting in San ... ages of 10 and 14. Boys undergo these changes ... Precocious puberty is diagnosed in girls when sexual development ... is diagnosed when these changes occur before age 9. ...
Breaking Biology News(10 mins):IQ link to baby's weight gain in first month 2Poor eating behaviors may put preschoolers at risk for later health problems 2Vitamin D supplementation may delay precocious puberty in girls 2
... Germany, November 14, 2011 DERMALOG Identification ... set a new world record in the identification of ... AFIS", is capable of correctly identifying the ten fingerprints ... of more than 129 million fingerprints. The renowned international ...
... Hospitals Case Medical Center researchers could still be close ... as they originally thought. LateTIME was a study ... that were believed to have the ability to improve ... heart within two weeks of the attack. Results are ...
... from heart failure due to a previous myocardial infarction ... following an investigative treatment that involved infusing them with ... percent improvement average the researchers projected for the Phase ... today (Nov. 14) in The Lancet and ...
Cached Biology News:World Record in Fingerprint Identification: DERMALOG Correctly Identifies 129 Million Fingerprints in one Second 2World Record in Fingerprint Identification: DERMALOG Correctly Identifies 129 Million Fingerprints in one Second 3Post heart attack recovery may not be aided by stem cell injections, but trial demonstrates promise 2Results triple researchers' projections with use of adult stem cells for heart failure 2